Similarly, Baccelli et al. showed that CTCs that were derived from human breast cancer patients and were competent enough to give rise to bone, lung, and liver metastases in mice were positive for EpCAM, CD44, CD47, and MET [37]. This evidence concerns the gene CD47 and breast cancer.